BRK-B vs GLQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GLQ presents as a deep-value opportunity, characterized by a stable Piotroski F-Score of 6/9 and a current price ($8.09) that trades at a massive discount to both its Graham Number ($19.35) and Intrinsic Value ($54.87). While the technical trend is severely bearish (10/100) and revenue growth is contracting (-29.70%), the fund's fundamental profitability remains strong with an ROE of 22.12% and a sustainable 10.81% dividend yield. The valuation metrics (P/E 4.35, P/B 0.90) suggest the market is significantly underpricing the asset's book value and earnings power.
Compare Another Pair
Related Comparisons
BRK-B vs GLQ: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Clough Global Equity Fund (GLQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.